Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS

被引：0

作者：

J Vincent

G Bernard

J Dhainaut

J Janes

T Wright

C Gaillez

机构：

[1] Erasme University Hospital,

[2] Vanderbilt University,undefined

[3] Cochin-Port Royal University Hospital,undefined

[4] Eli Lilly & Co.,undefined

[5] Eli Lilly & Co.,undefined

来源：

Critical Care | / 8卷 / Suppl 1期

关键词：

Severe Sepsis; Risk Profile; Multiple Organ Failure; Placebo Patient; Drotrecogin Alfa;

D O I：

10.1186/cc2582

中图分类号：

学科分类号：

摘要：

引用